A detailed history of Bartlett & Co. Wealth Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 23 shares of CRL stock, worth $4,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Holding current value
$4,069
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 18, 2025

BUY
$99.75 - $151.89 $2,294 - $3,493
23 New
23 $3.49 Million
Q3 2021

Feb 13, 2024

BUY
$372.64 - $458.3 $3,726 - $4,583
10 New
10 $4.13 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Bartlett & Co. Wealth Management LLC Portfolio

Follow Bartlett & Co. Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.